Renal and urinary disorders. Augmentin is a registered trade mark of the GSK group of companies. Clear glass 10 ml or 25 ml vials Type I or Type III glass with chlorobutyl rubber stopper and sealing ring Packs of 1, 5 or 10 vials Not all pack sizes may be marketed. Augmentin is solutions should not stable in be mixed with infusions containing glucose, dextran or bicarbonate.
The expiry date refers to the last day of that month. Any residual antibiotic solution should be discarded. To view content sources and attributions, please refer to our editorial policy.
Product subject to medical prescription which may be renewed B. Convulsions may occur in patients with impaired renal function or in those receiving high doses.
Appropriate monitoring should be undertaken when anticoagulants are prescribed concomitantly. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects see section 4.
Urinary tract infectionssuch as cystitis, urethritis, pyelonephritis. There are no other ingredients. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals. Find out more here. Augmentin is the group name for formulations containing 2, 4 and 5 parts of a broad spectrum penicillin, amoxycillin and 1 part of potassium clavulanate.
Preparation of solutions for intravenous infusion. The pharmacokinetics of amoxycillin and clavulanic acid are closely allied. This Augmentin powder for solution for injection or infusion provides a total daily dose of mg amoxicillin and mg clavulanic acid when administered as recommended below. Therefore, the ingestion of alcohol should be avoided during and for several days after treatment with Augmentin.
Moreover, adjustments in the dose of oral anticoagulants may be necessary see sections 4. Change to section 4.
Both substances are excreted into breast milk nothing is known of the effects of clavulanic acid on the breast-fed infant. The Midwife's Pocket Formulary provides both practising midwives and students with key information on the administration and management of medications in midwifery practice.
This information has been compiled for use by healthcare practitioners and consumers in the United States.